Next Article in Journal
Molecular Mechanism of Gastric Carcinogenesis in Helicobacter pylori-Infected Rodent Models
Next Article in Special Issue
The Significance of Pulmonary Artery Size in Pulmonary Hypertension
Previous Article in Journal / Special Issue
The Role of Exercise Testing in the Modern Management of Pulmonary Arterial Hypertension
Article Menu

Export Article

Open AccessArticle
Diseases 2014, 2(2), 148-167; doi:10.3390/diseases2020148

NF-κB Activation Exacerbates, but Is not Required for Murine Bmpr2-Related Pulmonary Hypertension

1
Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA
2
Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Johann Wolfgang Goethe, Frankfurt 60590, Germany
3
Department of Anesthesiology, University of Colorado Health Sciences Center, Denver, CO 80045, USA
These authors contributed equally to this work.
*
Author to whom correspondence should be addressed.
Received: 18 April 2014 / Revised: 20 May 2014 / Accepted: 21 May 2014 / Published: 30 May 2014
(This article belongs to the Special Issue Pulmonary Arterial Hypertension (PAH))
View Full-Text   |   Download PDF [1747 KB, uploaded 5 June 2014]   |  

Abstract

Aim: The present study investigates the role of NF-κB in Bmpr2-related pulmonary hypertension (PH) using a murine model of PH with inducible overexpression of a cytoplasmic tail Bmpr2 mutation. Methods and Results: Electrophoretic mobility shift assay for nuclear extracts in Bmpr2R899X mouse lung and immunohistochemistry for NF-κB p65 in human PAH lung demonstrate that NF-κB is activated in end-stage disease. Acute inflammation or expression of a constitutively active NF-κB elicits a strong suppression of the BMP pathway in mice inversely correlating to activation of NF-κB targets. However, Bmpr2 mutation does not result in NF-κB activation in early disease development as assessed by luciferase reporter mice. Moreover, Bmpr2 mutant mice in which NF-κB activation is genetically blocked develop PH indistinguishable from that without the block. Finally, delivery of a virus causing NF-κB activation strongly exacerbates development of PH in Bmpr2 mutant mice, associated with increased remodeling. Conclusion: NF-κB activation exacerbates, but is not required for Bmpr2-related PH. Pulmonary vascular-specific activation of NF-κB may be a “second hit” that drives penetrance in heritable PH. View Full-Text
Keywords: pulmonary arterial hypertension; bone morphogenic protein receptor type 2; NF-κB; inflammation pulmonary arterial hypertension; bone morphogenic protein receptor type 2; NF-κB; inflammation
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Talati, M.; Mutlak, H.; Lane, K.B.; Han, W.; Hemnes, A.; Mutlak, O.; Blackwell, T.; Zaynagetdinov, R.; Blackwell, T.S.; West, J. NF-κB Activation Exacerbates, but Is not Required for Murine Bmpr2-Related Pulmonary Hypertension. Diseases 2014, 2, 148-167.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Diseases EISSN 2079-9721 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top